MedTrace Logo

Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds

NCT06885775 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-03-20

No results posted yet for this study

Summary

Purpose of this study is the demonstration of safety and efficacy of the dermal fillers DXP01 Face for restoration of moderate to severe nasolabial folds

Conditions

  • Dermal Fillers
  • Nasolabial Folds, Wrinkles

Interventions

DEVICE

DXP01

PCL Dermal Filler

DEVICE

Juvederm ULTRA 3

HA Dermal filler

Sponsors & Collaborators

  • DEXLEVO

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-28
Primary Completion
2027-04-01
Completion
2027-12-01

Countries

  • Romania

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06885775 on ClinicalTrials.gov